Selected research
Market Outlook & Growth Opportunities
Global Non-ionic Iodine Contrast Media Market Outlook and Growth Opportunities 2026
Market perspective
The global Non-ionic Iodine Contrast Media market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Non-ionic Iodine Contrast Media market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Non-ionic Iodine Contrast Media market include YRPG, Hengrui Medicine, BeiLu Pharma, Bayer, Sanochemia, Imax, Guerbet Group, GE Healthcare and Bracco Imaging, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Non-ionic Iodine Contrast Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Non-ionic Iodine Contrast Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Non-ionic Iodine Contrast Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-ionic Iodine Contrast Media market size, projected growth trends, production technologies, key applications, and end-use industries.
Non-ionic Iodine Contrast Media Segment by Company
YRPG
Hengrui Medicine
BeiLu Pharma
Bayer
Sanochemia
Imax
Guerbet Group
GE Healthcare
Bracco Imaging
Non-ionic Iodine Contrast Media Segment by Type
Iopamidol
Iodixanol
Iohexol
Ioversol
Others
Non-ionic Iodine Contrast Media Segment by Application
Hospitals
Clinics
Non-ionic Iodine Contrast Media Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Non-ionic Iodine Contrast Media status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Non-ionic Iodine Contrast Media market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Non-ionic Iodine Contrast Media significant trends, drivers, influence factors in global and regions.
6. To analyze Non-ionic Iodine Contrast Media competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-ionic Iodine Contrast Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-ionic Iodine Contrast Media and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-ionic Iodine Contrast Media.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Non-ionic Iodine Contrast Media market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-ionic Iodine Contrast Media industry.
Chapter 3: Detailed analysis of Non-ionic Iodine Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Non-ionic Iodine Contrast Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Non-ionic Iodine Contrast Media in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Iopamidol
- Iodixanol
- Iohexol
- Ioversol
- Others
Applications
- Hospitals
- Clinics
Companies covered
- YRPG
- Hengrui Medicine
- BeiLu Pharma
- Bayer
- Sanochemia
- Imax
- Guerbet Group
- GE Healthcare
- Bracco Imaging
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Non-ionic Iodine Contrast Media Sales Value (2021-2032)
- 1.2.2 Global Non-ionic Iodine Contrast Media Sales Volume (2021-2032)
- 1.2.3 Global Non-ionic Iodine Contrast Media Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Non-ionic Iodine Contrast Media Market Dynamics
- 2.1 Non-ionic Iodine Contrast Media Industry Trends
- 2.2 Non-ionic Iodine Contrast Media Industry Drivers
- 2.3 Non-ionic Iodine Contrast Media Industry Opportunities and Challenges
- 2.4 Non-ionic Iodine Contrast Media Industry Restraints
3 Non-ionic Iodine Contrast Media Market by Company
- 3.1 Global Non-ionic Iodine Contrast Media Company Revenue Ranking in 2025
- 3.2 Global Non-ionic Iodine Contrast Media Revenue by Company (2021-2026)
- 3.3 Global Non-ionic Iodine Contrast Media Sales Volume by Company (2021-2026)
- 3.4 Global Non-ionic Iodine Contrast Media Average Price by Company (2021-2026)
- 3.5 Global Non-ionic Iodine Contrast Media Company Ranking (2024-2026)
- 3.6 Global Non-ionic Iodine Contrast Media Company Manufacturing Base and Headquarters
- 3.7 Global Non-ionic Iodine Contrast Media Company Product Type and Application
- 3.8 Global Non-ionic Iodine Contrast Media Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Non-ionic Iodine Contrast Media Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Non-ionic Iodine Contrast Media Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Non-ionic Iodine Contrast Media Market by Type
- 4.1 Non-ionic Iodine Contrast Media Type Introduction
- 4.1.1 Iopamidol
- 4.1.2 Iodixanol
- 4.1.3 Iohexol
- 4.1.4 Ioversol
- 4.1.5 Others
- 4.2 Global Non-ionic Iodine Contrast Media Sales Volume by Type
- 4.2.1 Global Non-ionic Iodine Contrast Media Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Non-ionic Iodine Contrast Media Sales Volume by Type (2021-2032)
- 4.2.3 Global Non-ionic Iodine Contrast Media Sales Volume Share by Type (2021-2032)
- 4.3 Global Non-ionic Iodine Contrast Media Sales Value by Type
- 4.3.1 Global Non-ionic Iodine Contrast Media Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Non-ionic Iodine Contrast Media Sales Value by Type (2021-2032)
- 4.3.3 Global Non-ionic Iodine Contrast Media Sales Value Share by Type (2021-2032)
5 Non-ionic Iodine Contrast Media Market by Application
- 5.1 Non-ionic Iodine Contrast Media Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.2 Global Non-ionic Iodine Contrast Media Sales Volume by Application
- 5.2.1 Global Non-ionic Iodine Contrast Media Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Non-ionic Iodine Contrast Media Sales Volume by Application (2021-2032)
- 5.2.3 Global Non-ionic Iodine Contrast Media Sales Volume Share by Application (2021-2032)
- 5.3 Global Non-ionic Iodine Contrast Media Sales Value by Application
- 5.3.1 Global Non-ionic Iodine Contrast Media Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Non-ionic Iodine Contrast Media Sales Value by Application (2021-2032)
- 5.3.3 Global Non-ionic Iodine Contrast Media Sales Value Share by Application (2021-2032)
6 Non-ionic Iodine Contrast Media Regional Sales and Value Analysis
- 6.1 Global Non-ionic Iodine Contrast Media Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Non-ionic Iodine Contrast Media Sales by Region (2021-2032)
- 6.2.1 Global Non-ionic Iodine Contrast Media Sales by Region: 2021-2026
- 6.2.2 Global Non-ionic Iodine Contrast Media Sales by Region (2027-2032)
- 6.3 Global Non-ionic Iodine Contrast Media Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Non-ionic Iodine Contrast Media Sales Value by Region (2021-2032)
- 6.4.1 Global Non-ionic Iodine Contrast Media Sales Value by Region: 2021-2026
- 6.4.2 Global Non-ionic Iodine Contrast Media Sales Value by Region (2027-2032)
- 6.5 Global Non-ionic Iodine Contrast Media Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Non-ionic Iodine Contrast Media Sales Value (2021-2032)
- 6.6.2 North America Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Non-ionic Iodine Contrast Media Sales Value (2021-2032)
- 6.7.2 Europe Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Non-ionic Iodine Contrast Media Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Non-ionic Iodine Contrast Media Sales Value (2021-2032)
- 6.9.2 South America Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Non-ionic Iodine Contrast Media Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
7 Non-ionic Iodine Contrast Media Country-level Sales and Value Analysis
- 7.1 Global Non-ionic Iodine Contrast Media Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Non-ionic Iodine Contrast Media Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Non-ionic Iodine Contrast Media Sales by Country (2021-2032)
- 7.3.1 Global Non-ionic Iodine Contrast Media Sales by Country (2021-2026)
- 7.3.2 Global Non-ionic Iodine Contrast Media Sales by Country (2027-2032)
- 7.4 Global Non-ionic Iodine Contrast Media Sales Value by Country (2021-2032)
- 7.4.1 Global Non-ionic Iodine Contrast Media Sales Value by Country (2021-2026)
- 7.4.2 Global Non-ionic Iodine Contrast Media Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.9.2 France Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.16.2 China Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.19.2 India Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 YRPG
- 8.1.1 YRPG Company Information
- 8.1.2 YRPG Business Overview
- 8.1.3 YRPG Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
- 8.1.4 YRPG Non-ionic Iodine Contrast Media Product Portfolio
- 8.1.5 YRPG Recent Developments
- 8.2 Hengrui Medicine
- 8.2.1 Hengrui Medicine Company Information
- 8.2.2 Hengrui Medicine Business Overview
- 8.2.3 Hengrui Medicine Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Hengrui Medicine Non-ionic Iodine Contrast Media Product Portfolio
- 8.2.5 Hengrui Medicine Recent Developments
- 8.3 BeiLu Pharma
- 8.3.1 BeiLu Pharma Company Information
- 8.3.2 BeiLu Pharma Business Overview
- 8.3.3 BeiLu Pharma Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
- 8.3.4 BeiLu Pharma Non-ionic Iodine Contrast Media Product Portfolio
- 8.3.5 BeiLu Pharma Recent Developments
- 8.4 Bayer
- 8.4.1 Bayer Company Information
- 8.4.2 Bayer Business Overview
- 8.4.3 Bayer Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Bayer Non-ionic Iodine Contrast Media Product Portfolio
- 8.4.5 Bayer Recent Developments
- 8.5 Sanochemia
- 8.5.1 Sanochemia Company Information
- 8.5.2 Sanochemia Business Overview
- 8.5.3 Sanochemia Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Sanochemia Non-ionic Iodine Contrast Media Product Portfolio
- 8.5.5 Sanochemia Recent Developments
- 8.6 Imax
- 8.6.1 Imax Company Information
- 8.6.2 Imax Business Overview
- 8.6.3 Imax Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Imax Non-ionic Iodine Contrast Media Product Portfolio
- 8.6.5 Imax Recent Developments
- 8.7 Guerbet Group
- 8.7.1 Guerbet Group Company Information
- 8.7.2 Guerbet Group Business Overview
- 8.7.3 Guerbet Group Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Guerbet Group Non-ionic Iodine Contrast Media Product Portfolio
- 8.7.5 Guerbet Group Recent Developments
- 8.8 GE Healthcare
- 8.8.1 GE Healthcare Company Information
- 8.8.2 GE Healthcare Business Overview
- 8.8.3 GE Healthcare Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
- 8.8.4 GE Healthcare Non-ionic Iodine Contrast Media Product Portfolio
- 8.8.5 GE Healthcare Recent Developments
- 8.9 Bracco Imaging
- 8.9.1 Bracco Imaging Company Information
- 8.9.2 Bracco Imaging Business Overview
- 8.9.3 Bracco Imaging Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Bracco Imaging Non-ionic Iodine Contrast Media Product Portfolio
- 8.9.5 Bracco Imaging Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Non-ionic Iodine Contrast Media Value Chain Analysis
- 9.1.1 Non-ionic Iodine Contrast Media Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Non-ionic Iodine Contrast Media Sales Mode & Process
- 9.2 Non-ionic Iodine Contrast Media Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Non-ionic Iodine Contrast Media Distributors
- 9.2.3 Non-ionic Iodine Contrast Media Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst